Inventor · disambiguated record
Hilary Plake Beck
Also filed as: BECK HILARY · BECK HILARY PLAKE
28 granted patents·17 pending applications·94 citations·filing 2007–2023
95Inventor score
Files withAMGEN INC14IDEAYA BIOSCIENCES INC13FLEXUS BIOSCIENCES INC7BRISTOL MYERS SQUIBB CO5RAPT THERAPEUTICS INC3
Top patents by PatentIndex Score
45 records- 0196US9643972B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2015·Granted May 9, 2017·15 cites·47 claims
- 0296US9598422B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2015·Granted Mar 21, 2017·21 cites·34 claims
- 0393US10106546B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2017·Granted Oct 23, 2018·6 cites·66 claims
- 0491US10246462B2Chemokine receptor modulators and uses thereofFLX BIO INC·Filed 2017·Granted Apr 2, 2019·10 cites·77 claims
- 0590US10179787B2Chemokine receptor modulators and uses thereofFLX BIO INC·Filed 2017·Granted Jan 15, 2019·5 cites·38 claims
- 0689US10533014B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2018·Granted Jan 14, 2020·3 cites·20 claims
- 0788US9593129B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2016·Granted Mar 14, 2017·5 cites·18 claims
- 0888US9296736B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2014·Granted Mar 29, 2016·7 cites·13 claims
- 0987US10815250B2AhR modulatorsIDEAYA BIOSCIENCES INC·Filed 2019·Granted Oct 27, 2020·3 cites·24 claims
- 1087US10604526B2Chemokine receptor modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2018·Granted Mar 31, 2020·2 cites·25 claims
- 1187US2024300892A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2023·Application pending·0 cites
- 1286US9376425B2Heterocyclic compounds as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2012·Granted Jun 28, 2016·12 cites·37 claims
- 1384US11407764B2AhR modulatorsIDEAYA BIOSCIENCES INC·Filed 2020·Granted Aug 9, 2022·1 cites·19 claims
- 1481US2024199620A1Chemokine receptor modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1580US2022169611A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2022·Application pending·0 cites
- 1675US11584755B2Dihydrothieno[3,2-b]pyridine compoundsIDEAYA BIOSCIENCES INC·Filed 2018·Granted Feb 21, 2023·1 cites·18 claims
- 1774US12258354B2AhR modulatorsIDEAYA BIOSCIENCES INC·Filed 2022·Granted Mar 25, 2025·0 cites·14 claims
- 1874US2021179560A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2020·Application pending·0 cites
- 1973US8003648B2Heterocyclic GPR40 modulatorsAMGEN INC·Filed 2009·Granted Aug 23, 2011·1 cites·10 claims
- 2072US9365522B2Pyrazole amide derivativeAMGEN INC·Filed 2015·Granted Jun 14, 2016·2 cites·14 claims
- 2172US2022127233A1Substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparationBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 2270US11919863B2Substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparationBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Mar 5, 2024·0 cites·17 claims
- 2369US12421195B2Amorphous and crystalline forms of IDO inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Sep 23, 2025·0 cites·12 claims
- 2467US2019062276A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2018·Application pending·0 cites
- 2566US11932601B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2021·Granted Mar 19, 2024·0 cites·17 claims
- 2666US2020239480A1Chemokine receptor modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2765US2014011796A1Piperidinone derivatives as mdm2 inhibitors for the treatment of cancerAMGEN INC·Filed 2013·Application pending·0 cites
- 2864US2017144971A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2017·Application pending·0 cites
- 2963US11236049B2Amorphous and crystalline forms of IDO inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Feb 1, 2022·0 cites·4 claims
- 3061US11236048B2Substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparationBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Feb 1, 2022·0 cites·16 claims
- 3157US12509454B2Thiadiazolyl derivativesIDEAYA BIOSCIENCES INC·Filed 2020·Granted Dec 30, 2025·0 cites·7 claims
- 3257US11242319B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2015·Granted Feb 8, 2022·0 cites·23 claims
- 3356US10206893B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2017·Granted Feb 19, 2019·0 cites·23 claims
- 3456US7714008B2Heterocyclic GPR40 modulatorsAMGEN INC·Filed 2007·Granted May 11, 2010·0 cites·11 claims
- 3556US2023086732A1Photoactive fluorescent compounds and use thereof for labeling of proteinsEIKON THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3654US2025325552A1Substituted thiadiazolyl derivatives as dna polymerase theta inhibitorsIDEAYA BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 3750US2023303510A1Cyclized acetamido derivatives as dna polymerase theta inhibitorsIDEAYA BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 3849US2022340875A1Methods of culturing and/or expanding stem cells and/or lineage committed progenitor cells using amido compoundsIDEAYA BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 3948US2021254006A1Methods of culturing and/or expanding stem cells and/or lineage committed progenitor cells using lactam compoundsIDEAYA BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 4047US2022098154A1Acetamido derivatives as dna polymerase theta inhibitorsIDEAYA BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 4146US2016002185A1Cis-morpholinone and other compounds as mdm2 inhibitors for the treatment of cancerAMGEN INC·Filed 2014·Application pending·0 cites
- 4245US11548867B2Amido compounds as AhR modulatorsIDEAYA BIOSCIENCES INC·Filed 2018·Granted Jan 10, 2023·0 cites·19 claims
- 4345US11530220B2Substituted imidazo[1,5-a]pyrazines and [1,2,4]triazolo[4,3-a]pyrazines for the modulation of AhRIDEAYA BIOSCIENCES INC·Filed 2019·Granted Dec 20, 2022·0 cites·21 claims
- 4444US2021387968A1Heteroarylmethylene derivatives as dna polymerase theta inhibitorsIDEAYA BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 4543US11407721B2CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2018·Granted Aug 9, 2022·0 cites·46 claims
Join the waitlist — get patent alerts
Get an alert when Hilary Plake Beck files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →